XML 99 R76.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Incentive Plan      
Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value      
Exercised   $ 863 $ 3,601
Inducement Plan      
Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value      
Exercised   $ 495 $ 1,803
Share-based Payment Arrangement, Option | Incentive Plan      
Shares (in thousands)      
Outstanding, beginning balance (in shares) 39,082    
Granted (in shares) 4,714    
Exercised (in shares) (1,224)    
Cancelled or Forfeited (in shares) (3,908)    
Outstanding, ending balance (in shares) 38,664 39,082  
Exercisable (in shares) 26,503    
Vested and expected to vest (in shares) 37,372    
Weighted Average Exercise Price per Share      
Outstanding, beginning balance (in usd per share) $ 7.96    
Granted (in usd per share) 7.38    
Exercised (in usd per share) 5.23    
Cancelled or Forfeited (in usd per share) 9.34    
Outstanding, ending balance (in usd per share) 7.83 $ 7.96  
Exercisable (in usd per share) 7.98    
Vested and expected to vest (in usd per share) $ 7.84    
Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value      
Outstanding (in years) 5 years 8 months 1 day    
Exercisable (in years) 4 years 4 months 20 days    
Vested and expected to vest (in years) 5 years 6 months 25 days    
Exercised $ 4,139    
Outstanding at December 31, 2025 34,248    
Exercisable at December 31, 2025 26,715    
Vested and expected to vest at December 31, 2025 $ 33,360    
Share-based Payment Arrangement, Option | Inducement Plan      
Shares (in thousands)      
Outstanding, beginning balance (in shares) 5,158    
Granted (in shares) 268    
Exercised (in shares) (266)    
Cancelled or Forfeited (in shares) (480)    
Outstanding, ending balance (in shares) 4,680 5,158  
Exercisable (in shares) 3,607    
Vested and expected to vest (in shares) 4,432    
Weighted Average Exercise Price per Share      
Outstanding, beginning balance (in usd per share) $ 8.44    
Granted (in usd per share) 7.57    
Exercised (in usd per share) 5.66    
Cancelled or Forfeited (in usd per share) 10.54    
Outstanding, ending balance (in usd per share) 8.33 $ 8.44  
Exercisable (in usd per share) 8.24    
Vested and expected to vest (in usd per share) $ 8.33    
Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value      
Outstanding (in years) 4 years 4 months 28 days    
Exercisable (in years) 3 years 8 months 12 days    
Vested and expected to vest (in years) 4 years 5 months 15 days    
Exercised $ 1,018    
Outstanding at December 31, 2025 7,454    
Exercisable at December 31, 2025 6,758    
Vested and expected to vest at December 31, 2025 $ 7,247